Linagliptin

Generic name: Pronounced as (lin'' a glip' tin)
Brand names
  • Tradjenta®
  • Trijardy® (as a combination product containing Empagliflozin, Linagliptin, Metformin)
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2020

Linagliptin is used along with diet and exercise and sometimes with other medications to lower blood sugar levels in patients with type 2 diabetes (condition in which blood sugar is too high because the body does not produce or use insulin normally). Linagliptin is in a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by increasing the amounts of certain natural substances that lower blood sugar when it is high. Linagliptin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Linagliptin used in combination with insulin to treat diabetes has not been studied to date.

Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking medication(s), making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.

Linagliptin comes as a tablet to take by mouth. It is usually taken once a day with or without food. Take linagliptin at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take linagliptin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Linagliptin helps to control high blood sugar but does not cure diabetes. Continue to take linagliptin even if you feel well. Do not stop taking linagliptin without talking to your doctor.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with linagliptin and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking linagliptin,

  • tell your doctor and pharmacist if you are allergic to linagliptin, any other medications, or any of the ingredients in linagliptin tablets. Ask your pharmacist or check the manufacturer's patient information for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking or plan to take. Be sure to mention any of the following: carbamazepine (Tegretol); insulin; oral medications for diabetes such as acetohexamide, chlorpropamide (Diabinese), glimepiride (Amaryl, in Avandaryl), glipizide (Glucotrol, in Metaglip), glyburide (Diabeta, Glynase, Micronase, in Glucovance), nateglinide (Starlix), pioglitazone (Actos, in Actoplus Met, in Duetact), repaglinide (Prandin), rosiglitazone (Avandia, in Avandamet, in Avandaryl), tolazamide, and tolbutamide; phenytoin (Dilantin); phenobarbital; rifabutin (Mycobutin); rifampin (Rifadin, in Rifamate, in Rifater); and ritonavir (Norvir, in Kaletra). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor and pharmacist what herbal products you are taking or plan to take, especially St. John's wort.

  • tell your doctor if you have or have ever had pancreatitis (inflammation of your pancreas), gallstones (stones in your gallbladder), or high triglycerides (a fatty substance in the blood), or if you drink or have ever drunk large amounts of alcohol.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking linagliptin, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking linagliptin.

  • talk to your doctor about what you should do if you get hurt or if you develop a fever or infection. These conditions may affect your blood sugar and the amount of linagliptin you may need for treatment.

Be sure to follow all diet and exercise recommendations made by your doctor or dietician. It is important to eat a healthy diet, exercise regularly, and lose weight if necessary. This will help to control your diabetes and help linagliptin work more effectively.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

This medication may cause changes in your blood sugar. You should know the symptoms of low and high blood sugar and what to do if you have these symptoms.

  • Linagliptin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • joint pain

  • Some side effects can be serious. If you experience any of these symptoms, stop taking linagliptin and call your doctor immediately or get emergency medical treatment:

    • rash

    • itching, flaking, or peeling of the skin

    • hives

    • swelling of the face, lips, tongue, or throat

    • difficulty breathing or swallowing

    • hoarseness

    • ongoing pain that begins in the upper left or middle of the stomach but may spread to the back

    • nausea

    • vomiting

    • loss of appetite

  • Linagliptin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your blood sugar and glycosylated hemoglobin (HbA1c) should be checked regularly to determine your response to linagliptin. Your doctor will also tell you how to check your response to linagliptin by measuring your blood sugar levels at home. Follow these instructions carefully.

You should always wear a diabetic identification bracelet to be sure you get proper treatment in an emergency.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Glyxambi® (containing Linagliptin, Empagliflozin)
  • Jentadueto® (containing Linagliptin, Metformin)

Drug Interaction
Moxifloxacin Moxifloxacin The therapeutic efficacy of Linagliptin can be increased when used in combination with Moxifloxacin.
Repaglinide Repaglinide The risk or severity of hypoglycemia can be increased when Repaglinide is combined with Linagliptin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection Linagliptin may increase the hypoglycemic activities of Insulin glargine.
Delavirdine Delavirdine The metabolism of Linagliptin can be decreased when combined with Delavirdine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Linagliptin.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Linagliptin.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Linagliptin.
Clopidogrel Clopidogrel The serum concentration of Linagliptin can be increased when it is combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Linagliptin can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Linagliptin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Linagliptin.
Guanfacine Guanfacine The risk or severity of adverse effects can be increased when Linagliptin is combined with Guanfacine.
Methylergonovine Methylergonovine The metabolism of Linagliptin can be decreased when combined with Methylergometrine.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Miglitol is combined with Linagliptin.
Olsalazine Olsalazine Olsalazine may increase the hypoglycemic activities of Linagliptin.
Paregoric Paregoric The serum concentration of Morphine can be increased when it is combined with Linagliptin.
Penbutolol Penbutolol The therapeutic efficacy of Acebutolol can be increased when used in combination with Linagliptin.
Prednisone Prednisone The risk or severity of hyperglycemia can be increased when Prednisone is combined with Linagliptin.
Ranitidine Ranitidine The serum concentration of Linagliptin can be increased when it is combined with Ranitidine.
Reserpine Reserpine The serum concentration of Linagliptin can be increased when it is combined with Reserpine.
Sumatriptan Sumatriptan The therapeutic efficacy of Linagliptin can be increased when used in combination with Sumatriptan.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Linagliptin.
Triamcinolone Triamcinolone The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Linagliptin.
Doxycycline Injection Doxycycline Injection The metabolism of Linagliptin can be decreased when combined with Doxycycline.
Famotidine Injection Famotidine Injection The serum concentration of Linagliptin can be increased when it is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Fluconazole.
Levofloxacin Injection Levofloxacin Injection The therapeutic efficacy of Linagliptin can be increased when used in combination with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Linagliptin.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Methylprednisolone.
Metronidazole Injection Metronidazole Injection The metabolism of Linagliptin can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Morphine can be increased when it is combined with Linagliptin.
Altretamine Altretamine Amphetamine may increase the hypoglycemic activities of Linagliptin.
Cyclosporine Cyclosporine The serum concentration of Cyclosporine can be increased when it is combined with Linagliptin.
Torsemide Torsemide The therapeutic efficacy of Linagliptin can be increased when used in combination with Torasemide.
Olanzapine Olanzapine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Olanzapine.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Linagliptin.
Eprosartan Eprosartan The risk or severity of angioedema can be increased when Eprosartan is combined with Linagliptin.
Hydroxychloroquine Hydroxychloroquine The therapeutic efficacy of Linagliptin can be increased when used in combination with Hydroxychloroquine.
Orlistat Orlistat The metabolism of Linagliptin can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Linagliptin can be increased when combined with Oxcarbazepine.
Telmisartan Telmisartan The risk or severity of angioedema can be increased when Telmisartan is combined with Linagliptin.
Anakinra Anakinra The metabolism of Linagliptin can be increased when combined with Anakinra.
Linezolid Linezolid Linezolid may increase the hypoglycemic activities of Linagliptin.
Trimipramine Trimipramine The serum concentration of Linagliptin can be increased when it is combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Linagliptin can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Linagliptin can be increased when combined with Modafinil.
Perindopril Perindopril The risk or severity of angioedema can be increased when Perindopril is combined with Linagliptin.
Tenofovir Tenofovir The serum concentration of Tenofovir can be increased when it is combined with Linagliptin.
Sirolimus Sirolimus The serum concentration of Sirolimus can be increased when it is combined with Linagliptin.
Epinephrine Injection Epinephrine Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Epinephrine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Linagliptin.
Escitalopram Escitalopram The risk or severity of hypoglycemia can be increased when Escitalopram is combined with Linagliptin.
Zonisamide Zonisamide The serum concentration of Linagliptin can be increased when it is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Linagliptin can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Linagliptin.
Atazanavir Atazanavir The metabolism of Linagliptin can be decreased when combined with Atazanavir.
Mefloquine Mefloquine The metabolism of Linagliptin can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The therapeutic efficacy of Linagliptin can be increased when used in combination with Rosuvastatin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Linagliptin.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Linagliptin.
Aprepitant Aprepitant The metabolism of Linagliptin can be decreased when combined with Aprepitant.
Memantine Memantine The serum concentration of Memantine can be increased when it is combined with Linagliptin.
Tegaserod Tegaserod The serum concentration of Tegaserod can be increased when it is combined with Linagliptin.
Fosamprenavir Fosamprenavir The therapeutic efficacy of Linagliptin can be decreased when used in combination with Fosamprenavir.
Gemifloxacin Gemifloxacin The therapeutic efficacy of Linagliptin can be increased when used in combination with Gemifloxacin.
Progesterone Progesterone The therapeutic efficacy of Linagliptin can be decreased when used in combination with Progesterone.
Infliximab Injection Infliximab Injection The metabolism of Linagliptin can be increased when combined with Infliximab.
Oxandrolone Oxandrolone Oxandrolone may increase the hypoglycemic activities of Linagliptin.
Protriptyline Protriptyline Protriptyline may decrease the hypoglycemic activities of Linagliptin.
Rifaximin Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Linagliptin.
Duloxetine Duloxetine The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Linagliptin.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Linagliptin.
Bosentan Bosentan The metabolism of Linagliptin can be increased when combined with Bosentan.
Erlotinib Erlotinib The metabolism of Linagliptin can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Linagliptin.
Ganciclovir Ganciclovir The risk or severity of adverse effects can be increased when Linagliptin is combined with Ganciclovir.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection Linagliptin may increase the hypoglycemic activities of Insulin aspart.
Voriconazole Voriconazole The metabolism of Linagliptin can be decreased when combined with Voriconazole.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the hypoglycemic activities of Linagliptin.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Linagliptin.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Exenatide is combined with Linagliptin.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypoglycemic activities of Linagliptin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Linagliptin.
Pregabalin Pregabalin The risk or severity of angioedema can be increased when Pregabalin is combined with Linagliptin.
Deferasirox Deferasirox The metabolism of Linagliptin can be increased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Tipranavir can be decreased when it is combined with Linagliptin.
Felbamate Felbamate The metabolism of Linagliptin can be increased when combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection Linagliptin may increase the hypoglycemic activities of Insulin detemir.
Ranolazine Ranolazine The serum concentration of Linagliptin can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Linagliptin can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypoglycemic activities of Linagliptin.
Imatinib Imatinib The serum concentration of Linagliptin can be increased when it is combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Sitagliptin can be increased when it is combined with Linagliptin.
Varenicline Varenicline The excretion of Varenicline can be decreased when combined with Linagliptin.
Gefitinib Gefitinib The metabolism of Linagliptin can be decreased when combined with Gefitinib.
Paliperidone Paliperidone The serum concentration of Linagliptin can be increased when it is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Bortezomib can be decreased when combined with Linagliptin.
Clofarabine Injection Clofarabine Injection The serum concentration of Clofarabine can be increased when it is combined with Linagliptin.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection Linagliptin may increase the hypoglycemic activities of Insulin glulisine.
Oxaliplatin Injection Oxaliplatin Injection The serum concentration of Oxaliplatin can be increased when it is combined with Linagliptin.
Posaconazole Posaconazole The metabolism of Linagliptin can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Linagliptin can be decreased when combined with Primaquine.
Bismuth Subsalicylate Bismuth Subsalicylate Bismuth subsalicylate may increase the hypoglycemic activities of Linagliptin.
Darunavir Darunavir The metabolism of Linagliptin can be decreased when combined with Darunavir.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Linagliptin.
Vorinostat Vorinostat The therapeutic efficacy of Linagliptin can be decreased when used in combination with Vorinostat.
Sorafenib Sorafenib The metabolism of Linagliptin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Linagliptin can be decreased when combined with Sunitinib.
Lapatinib Lapatinib The serum concentration of Linagliptin can be increased when it is combined with Lapatinib.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Linagliptin.
Armodafinil Armodafinil The metabolism of Linagliptin can be increased when combined with Armodafinil.
Ivermectin Ivermectin The metabolism of Linagliptin can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Linagliptin.
Nilotinib Nilotinib The metabolism of Linagliptin can be decreased when combined with Nilotinib.
Toremifene Toremifene The serum concentration of Linagliptin can be increased when it is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Linagliptin can be increased when combined with Bexarotene.
Budesonide Budesonide The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Linagliptin can be decreased when combined with Chloramphenicol.
Etravirine Etravirine The serum concentration of Linagliptin can be decreased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Arsenic trioxide.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Linagliptin can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Linagliptin can be decreased when combined with Desvenlafaxine.
Nebivolol Nebivolol The therapeutic efficacy of Nebivolol can be increased when used in combination with Linagliptin.
Bendamustine Injection Bendamustine Injection The serum concentration of Bendamustine can be increased when it is combined with Linagliptin.
Pilocarpine Pilocarpine The metabolism of Linagliptin can be decreased when combined with Pilocarpine.
Certolizumab Injection Certolizumab Injection The metabolism of Linagliptin can be increased when combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Linagliptin.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Linagliptin.
Mitotane Mitotane The metabolism of Linagliptin can be increased when combined with Mitotane.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Linagliptin.
Silodosin Silodosin The serum concentration of Silodosin can be increased when it is combined with Linagliptin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Linagliptin.
Milnacipran Milnacipran The metabolism of Linagliptin can be decreased when combined with Milnacipran.
Betaxolol Betaxolol The therapeutic efficacy of Linagliptin can be increased when used in combination with Betaxolol.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Linagliptin.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Linagliptin.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Linagliptin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Tolvaptan can be increased when it is combined with Linagliptin.
Dronedarone Dronedarone The metabolism of Dronedarone can be decreased when combined with Linagliptin.
Saxagliptin Saxagliptin The risk or severity of angioedema can be increased when Saxagliptin is combined with Linagliptin.
Romidepsin Injection Romidepsin Injection The serum concentration of Romidepsin can be increased when it is combined with Linagliptin.
Topotecan Topotecan The serum concentration of Topotecan can be increased when it is combined with Linagliptin.
Golimumab Injection Golimumab Injection The metabolism of Linagliptin can be increased when combined with Golimumab.
Pazopanib Pazopanib The serum concentration of Pazopanib can be increased when it is combined with Linagliptin.
Asenapine Asenapine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Asenapine.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Linagliptin.
Levonorgestrel Levonorgestrel The therapeutic efficacy of Linagliptin can be decreased when used in combination with Levonorgestrel.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Linagliptin.
Tocilizumab Injection Tocilizumab Injection The metabolism of Linagliptin can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Linagliptin.
Cabazitaxel Injection Cabazitaxel Injection The serum concentration of Linagliptin can be increased when it is combined with Cabazitaxel.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Linagliptin.
Acetaminophen Injection Acetaminophen Injection The metabolism of Linagliptin can be increased when combined with Acetaminophen.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Linagliptin can be decreased when combined with Aldesleukin.
Azilsartan Azilsartan The risk or severity of angioedema can be increased when Azilsartan medoxomil is combined with Linagliptin.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Linagliptin.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Linagliptin can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The serum concentration of Glecaprevir can be increased when it is combined with Linagliptin.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Linagliptin can be decreased when combined with Cyclophosphamide.
Triptorelin Injection Triptorelin Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Triptorelin.
Rivaroxaban Rivaroxaban The serum concentration of Rivaroxaban can be increased when it is combined with Linagliptin.
Ticagrelor Ticagrelor The metabolism of Linagliptin can be decreased when combined with Ticagrelor.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Linagliptin.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Linagliptin.
Vandetanib Vandetanib The metabolism of Linagliptin can be decreased when combined with Vandetanib.
Clobazam Clobazam The serum concentration of Clobazam can be increased when it is combined with Linagliptin.
Vemurafenib Vemurafenib The serum concentration of Linagliptin can be increased when it is combined with Vemurafenib.
Ivacaftor Ivacaftor The metabolism of Linagliptin can be decreased when combined with Ivacaftor.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Linagliptin.
Crizotinib Crizotinib The serum concentration of Linagliptin can be increased when it is combined with Crizotinib.
Cabergoline Cabergoline The metabolism of Linagliptin can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Linagliptin can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Linagliptin.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Linagliptin.
Enzalutamide Enzalutamide The metabolism of Linagliptin can be increased when combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Mirabegron can be increased when it is combined with Linagliptin.
Regorafenib Regorafenib The serum concentration of Regorafenib can be increased when it is combined with Linagliptin.
Bosutinib Bosutinib The serum concentration of Bosutinib can be increased when it is combined with Linagliptin.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Linagliptin.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Mecasermin is combined with Linagliptin.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Linagliptin.
Alogliptin Alogliptin The risk or severity of angioedema can be increased when Alogliptin is combined with Linagliptin.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Linagliptin.
Pomalidomide Pomalidomide The serum concentration of Pomalidomide can be increased when it is combined with Linagliptin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The serum concentration of Trastuzumab emtansine can be increased when it is combined with Linagliptin.
Apixaban Apixaban The serum concentration of Apixaban can be increased when it is combined with Linagliptin.
Canagliflozin Canagliflozin The serum concentration of Canagliflozin can be increased when it is combined with Linagliptin.
Methazolamide Methazolamide The therapeutic efficacy of Linagliptin can be increased when used in combination with Methazolamide.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be increased when it is combined with Linagliptin.
Trametinib Trametinib The metabolism of Linagliptin can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Dolutegravir can be increased when it is combined with Linagliptin.
Afatinib Afatinib The serum concentration of Afatinib can be increased when it is combined with Linagliptin.
Levomilnacipran Levomilnacipran The risk or severity of hypoglycemia can be increased when Levomilnacipran is combined with Linagliptin.
Perampanel Perampanel The metabolism of Linagliptin can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Linagliptin.
Lomitapide Lomitapide The metabolism of Linagliptin can be decreased when combined with Lomitapide.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Linagliptin.
Simeprevir Simeprevir The serum concentration of Linagliptin can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Sofosbuvir can be increased when it is combined with Linagliptin.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the hypoglycemic activities of Linagliptin.
Apremilast Apremilast The metabolism of Linagliptin can be increased when combined with Apremilast.
Ceritinib Ceritinib The serum concentration of Ceritinib can be increased when it is combined with Linagliptin.
Siltuximab Injection Siltuximab Injection The metabolism of Linagliptin can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Albiglutide.
Eslicarbazepine Eslicarbazepine The metabolism of Linagliptin can be increased when combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The serum concentration of Belinostat can be increased when it is combined with Linagliptin.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Linagliptin.
Testosterone Injection Testosterone Injection The metabolism of Linagliptin can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Linagliptin can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The serum concentration of Linagliptin can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Linagliptin can be increased when it is combined with Suvorexant.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Dulaglutide.
Edoxaban Edoxaban The serum concentration of Edoxaban can be increased when it is combined with Linagliptin.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Linagliptin.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Linagliptin.
Lanreotide Injection Lanreotide Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Lanreotide.
Nintedanib Nintedanib The serum concentration of Nintedanib can be increased when it is combined with Linagliptin.
Secukinumab Injection Secukinumab Injection The metabolism of Linagliptin can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Linagliptin.
Insulin Human Inhalation Insulin Human Inhalation Linagliptin may increase the hypoglycemic activities of Insulin human.
Lenvatinib Lenvatinib The serum concentration of Lenvatinib can be increased when it is combined with Linagliptin.
Naloxegol Naloxegol The serum concentration of Naloxegol can be increased when it is combined with Linagliptin.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Linagliptin.
Haloperidol Injection Haloperidol Injection The serum concentration of Linagliptin can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine The metabolism of Ivabradine can be decreased when combined with Linagliptin.
Amiloride Amiloride The serum concentration of Linagliptin can be increased when it is combined with Amiloride.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Linagliptin can be increased when it is combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Linagliptin.
Flibanserin Flibanserin The metabolism of Linagliptin can be decreased when combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Linagliptin can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Prednisolone.
Daclatasvir Daclatasvir The serum concentration of Linagliptin can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Linagliptin.
Ziprasidone Injection Ziprasidone Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Ziprasidone.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection Linagliptin may increase the hypoglycemic activities of Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Linagliptin.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Linagliptin.
Osimertinib Osimertinib The serum concentration of Osimertinib can be increased when it is combined with Linagliptin.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Linagliptin.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Linagliptin.
Rifapentine Rifapentine The metabolism of Linagliptin can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Linagliptin can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Linagliptin can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Linagliptin.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Linagliptin.
Cobicistat Cobicistat The metabolism of Linagliptin can be decreased when combined with Cobicistat.
Selexipag Selexipag The serum concentration of Selexipag can be increased when it is combined with Linagliptin.
Diphenhydramine Injection Diphenhydramine Injection The serum concentration of Linagliptin can be increased when it is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Linagliptin can be increased when used in combination with Furosemide.
Rucaparib Rucaparib The serum concentration of Rucaparib can be increased when it is combined with Linagliptin.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Lixisenatide.
Ribociclib Ribociclib The metabolism of Linagliptin can be decreased when combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Linagliptin can be decreased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may decrease the hypoglycemic activities of Linagliptin.
Deflazacort Deflazacort The serum concentration of Linagliptin can be increased when it is combined with Deflazacort.
Safinamide Safinamide Safinamide may increase the hypoglycemic activities of Linagliptin.
Sarilumab Injection Sarilumab Injection The metabolism of Linagliptin can be increased when combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Linagliptin can be decreased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Linagliptin can be decreased when combined with Neratinib.
Enasidenib Enasidenib The metabolism of Linagliptin can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Linagliptin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Linagliptin can be increased when combined with Fosaprepitant.
Copanlisib Injection Copanlisib Injection The serum concentration of Copanlisib can be increased when it is combined with Linagliptin.
Delafloxacin Delafloxacin The therapeutic efficacy of Linagliptin can be increased when used in combination with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Linagliptin.
Betrixaban Betrixaban The serum concentration of Betrixaban can be increased when it is combined with Linagliptin.
Acalabrutinib Acalabrutinib The metabolism of Linagliptin can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The metabolism of Linagliptin can be decreased when combined with Letermovir.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Semaglutide.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Linagliptin can be increased when used in combination with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Linagliptin can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Linagliptin can be decreased when it is combined with Apalutamide.
Fostamatinib Fostamatinib The metabolism of Linagliptin can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The serum concentration of Avatrombopag can be increased when it is combined with Linagliptin.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Linagliptin.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Linagliptin.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Linagliptin.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Linagliptin.
Lusutrombopag Lusutrombopag The serum concentration of Lusutrombopag can be increased when it is combined with Linagliptin.
Elagolix Elagolix The serum concentration of Elagolix can be increased when it is combined with Linagliptin.
Tafenoquine Tafenoquine The serum concentration of Linagliptin can be increased when it is combined with Tafenoquine.
Dacomitinib Dacomitinib The serum concentration of Dacomitinib can be increased when it is combined with Linagliptin.
Duvelisib Duvelisib The serum concentration of Duvelisib can be increased when it is combined with Linagliptin.
Omadacycline Omadacycline The serum concentration of Omadacycline can be increased when it is combined with Linagliptin.
Sarecycline Sarecycline The serum concentration of Linagliptin can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Linagliptin can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Talazoparib can be increased when it is combined with Linagliptin.
Gilteritinib Gilteritinib The serum concentration of Gilteritinib can be increased when it is combined with Linagliptin.
Glasdegib Glasdegib The serum concentration of Glasdegib can be increased when it is combined with Linagliptin.
Larotrectinib Larotrectinib The serum concentration of Larotrectinib can be increased when it is combined with Linagliptin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Linagliptin can be decreased when combined with Paclitaxel.
Rifamycin Rifamycin The metabolism of Linagliptin can be increased when combined with Rifamycin.
Prucalopride Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Linagliptin.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Linagliptin can be increased when combined with Emapalumab.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Linagliptin is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic The risk or severity of adverse effects can be increased when Linagliptin is combined with Acyclovir.
Erdafitinib Erdafitinib The serum concentration of Linagliptin can be increased when it is combined with Erdafitinib.
Alpelisib Alpelisib The metabolism of Linagliptin can be decreased when combined with Alpelisib.
Solriamfetol Solriamfetol The serum concentration of Solriamfetol can be increased when it is combined with Linagliptin.
Darolutamide Darolutamide The serum concentration of Darolutamide can be increased when it is combined with Linagliptin.
Triclabendazole Triclabendazole The metabolism of Linagliptin can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Linagliptin.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Linagliptin.
Istradefylline Istradefylline The serum concentration of Linagliptin can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant The serum concentration of Linagliptin can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Linagliptin.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Linagliptin.
Lefamulin Lefamulin Linagliptin may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection The metabolism of Linagliptin can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Linagliptin can be increased when combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Enfortumab vedotin can be increased when it is combined with Linagliptin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Linagliptin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Linagliptin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Linagliptin.
Lasmiditan Lasmiditan The serum concentration of Linagliptin can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Linagliptin.
Tazemetostat Tazemetostat The serum concentration of Tazemetostat can be increased when it is combined with Linagliptin.
Cenobamate Cenobamate The serum concentration of Linagliptin can be decreased when it is combined with Cenobamate.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Teprotumumab.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Linagliptin.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Linagliptin.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Linagliptin.
Tucatinib Tucatinib Tucatinib may decrease the excretion rate of Linagliptin which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Linagliptin.
Ripretinib Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Linagliptin.
Lemborexant Lemborexant The serum concentration of Lemborexant can be increased when it is combined with Linagliptin.
Fostemsavir Fostemsavir The serum concentration of Fostemsavir can be increased when it is combined with Linagliptin.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Linagliptin.
Octreotide Octreotide The therapeutic efficacy of Linagliptin can be decreased when used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Linagliptin.
Pralsetinib Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Linagliptin.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Linagliptin can be decreased when it is combined with Satralizumab.
Relugolix Relugolix The serum concentration of Relugolix can be increased when it is combined with Linagliptin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The therapeutic efficacy of Linagliptin can be decreased when used in combination with Drospirenone.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Linagliptin can be increased when combined with Vitamin E.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Linagliptin.
Indomethacin Indomethacin The risk or severity of hypoglycemia can be increased when Indomethacin is combined with Linagliptin.
Trazodone Trazodone The serum concentration of Linagliptin can be decreased when it is combined with Trazodone.
Phenobarbital Phenobarbital The metabolism of Linagliptin can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Methotrexate can be decreased when combined with Linagliptin.
Primidone Primidone The metabolism of Linagliptin can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Linagliptin.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Chlorpromazine.
Diazepam Diazepam The metabolism of Linagliptin can be decreased when combined with Diazepam.
Flurazepam Flurazepam The serum concentration of Linagliptin can be increased when it is combined with Flurazepam.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Linagliptin.
Phenoxybenzamine Phenoxybenzamine The serum concentration of Linagliptin can be increased when it is combined with Phenoxybenzamine.
Amantadine Amantadine The serum concentration of Linagliptin can be increased when it is combined with Amantadine.
Codeine Codeine The risk or severity of adverse effects can be increased when Linagliptin is combined with Codeine.
Bromocriptine Bromocriptine The metabolism of Linagliptin can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Linagliptin can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Linagliptin can be decreased when combined with Phenelzine.
Procarbazine Procarbazine Procarbazine may increase the hypoglycemic activities of Linagliptin.
Tetracycline Tetracycline The metabolism of Linagliptin can be decreased when combined with Tetracycline.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Linagliptin.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfadiazine.
Methadone Methadone The metabolism of Linagliptin can be increased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Linagliptin can be decreased when combined with Oxybutynin.
Ibuprofen Ibuprofen The risk or severity of angioedema can be increased when Ibuprofen is combined with Linagliptin.
Orphenadrine Orphenadrine The metabolism of Linagliptin can be decreased when combined with Orphenadrine.
Phentermine Phentermine The therapeutic efficacy of Linagliptin can be increased when used in combination with Phentermine.
Amoxapine Amoxapine Amoxapine may decrease the hypoglycemic activities of Linagliptin.
Sulfasalazine Sulfasalazine Sulfasalazine may increase the hypoglycemic activities of Linagliptin.
Hydrocortisone Hydrocortisone The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Linagliptin.
Doxorubicin Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Linagliptin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Linagliptin is combined with Cytarabine.
Dactinomycin Dactinomycin The serum concentration of Linagliptin can be increased when it is combined with Dactinomycin.
Carbamazepine Carbamazepine The metabolism of Linagliptin can be decreased when combined with Carbamazepine.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Linagliptin.
Prazosin Prazosin The serum concentration of Prazosin can be increased when it is combined with Linagliptin.
Hydralazine Hydralazine The metabolism of Linagliptin can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The serum concentration of Linagliptin can be increased when it is combined with Cimetidine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Linagliptin.
Loperamide Loperamide The metabolism of Linagliptin can be decreased when combined with Loperamide.
Daunorubicin Daunorubicin The metabolism of Linagliptin can be decreased when combined with Daunorubicin.
Griseofulvin Griseofulvin The metabolism of Linagliptin can be increased when combined with Griseofulvin.
Digoxin Digoxin Linagliptin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine The serum concentration of Linagliptin can be increased when it is combined with Loxapine.
Quinine Quinine The serum concentration of Linagliptin can be increased when it is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Linagliptin.
Calcitriol Calcitriol The metabolism of Linagliptin can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Linagliptin can be increased when combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Linagliptin can be decreased when used in combination with Chlorothiazide.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Linagliptin can be decreased when used in combination with Chlorthalidone.
Metolazone Metolazone The therapeutic efficacy of Linagliptin can be decreased when used in combination with Metolazone.
Secobarbital Secobarbital The metabolism of Linagliptin can be increased when combined with Secobarbital.
Desipramine Desipramine Desipramine may decrease the hypoglycemic activities of Linagliptin.
Amitriptyline Amitriptyline Amitriptyline may decrease the hypoglycemic activities of Linagliptin.
Imipramine Imipramine The serum concentration of Linagliptin can be increased when it is combined with Imipramine.
Probenecid Probenecid The therapeutic efficacy of Linagliptin can be increased when used in combination with Probenecid.
Quinidine Quinidine The serum concentration of Quinidine can be increased when it is combined with Linagliptin.
Procainamide Procainamide The serum concentration of Linagliptin can be increased when it is combined with Procainamide.
Isoniazid Isoniazid The metabolism of Linagliptin can be decreased when combined with Isoniazid.
Rifampin Rifampin The serum concentration of Linagliptin can be decreased when it is combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of hypoglycemia can be increased when Disopyramide is combined with Linagliptin.
Valproic Acid Valproic Acid The metabolism of Linagliptin can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Linagliptin can be decreased when combined with Tamoxifen.
Levothyroxine Levothyroxine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Levothyroxine.
Liothyronine Liothyronine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Liothyronine.
Methimazole Methimazole The metabolism of Linagliptin can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide Linagliptin may increase the hypoglycemic activities of Chlorpropamide.
Tolbutamide Tolbutamide Linagliptin may increase the hypoglycemic activities of Tolbutamide.
Tolazamide Tolazamide Linagliptin may increase the hypoglycemic activities of Tolazamide.
Dinoprostone Dinoprostone The serum concentration of Linagliptin can be increased when it is combined with Dinoprostone.
Niacin Niacin The therapeutic efficacy of Linagliptin can be decreased when used in combination with Niacin.
Baclofen Baclofen The therapeutic efficacy of Linagliptin can be decreased when used in combination with Baclofen.
Chlorpheniramine Chlorpheniramine The serum concentration of Linagliptin can be increased when it is combined with Chlorpheniramine.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Linagliptin can be decreased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydrochlorothiazide.
Danazol Danazol The therapeutic efficacy of Linagliptin can be decreased when used in combination with Danazol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The therapeutic efficacy of Linagliptin can be increased when used in combination with Propranolol.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The serum concentration of Linagliptin can be increased when it is combined with Nortriptyline.
Amphotericin B Injection Amphotericin B Injection The metabolism of Linagliptin can be decreased when combined with Amphotericin B.
Nadolol Nadolol The therapeutic efficacy of Nadolol can be increased when used in combination with Linagliptin.
Fluoxymesterone Fluoxymesterone Fluoxymesterone may increase the hypoglycemic activities of Linagliptin.
Clomiphene Clomiphene The serum concentration of Clomifene can be increased when it is combined with Linagliptin.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Linagliptin.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Linagliptin.
Acetazolamide Acetazolamide The therapeutic efficacy of Linagliptin can be increased when used in combination with Acetazolamide.
Ketoconazole Ketoconazole The metabolism of Linagliptin can be decreased when combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Linagliptin.
Vincristine Injection Vincristine Injection The excretion of Vincristine can be decreased when combined with Linagliptin.
Captopril Captopril The risk or severity of angioedema can be increased when Linagliptin is combined with Captopril.
Vinblastine Vinblastine The metabolism of Vinblastine can be decreased when combined with Linagliptin.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Linagliptin can be decreased when used in combination with Etacrynic acid.
Metoprolol Metoprolol The therapeutic efficacy of Linagliptin can be increased when used in combination with Metoprolol.
Aspirin Aspirin The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Linagliptin.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Linagliptin.
Trimethoprim Trimethoprim The serum concentration of Linagliptin can be increased when it is combined with Trimethoprim.
Diltiazem Diltiazem The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Linagliptin.
Nifedipine Nifedipine The metabolism of Linagliptin can be increased when combined with Nifedipine.
Timolol Timolol The therapeutic efficacy of Timolol can be increased when used in combination with Linagliptin.
Verapamil Verapamil The metabolism of Linagliptin can be decreased when combined with Verapamil.
Atenolol Atenolol The therapeutic efficacy of Linagliptin can be increased when used in combination with Atenolol.
Pindolol Pindolol The therapeutic efficacy of Linagliptin can be increased when used in combination with Pindolol.
Cisplatin Injection Cisplatin Injection The serum concentration of Linagliptin can be increased when it is combined with Cisplatin.
Diflunisal Diflunisal Diflunisal may increase the hypoglycemic activities of Linagliptin.
Bumetanide Bumetanide The therapeutic efficacy of Linagliptin can be increased when used in combination with Bumetanide.
Etoposide Etoposide The serum concentration of Linagliptin can be increased when it is combined with Etoposide.
Glyburide Glyburide The risk or severity of hypoglycemia can be increased when Glyburide is combined with Linagliptin.
Glipizide Glipizide Linagliptin may increase the hypoglycemic activities of Glipizide.
Indapamide Indapamide The therapeutic efficacy of Linagliptin can be decreased when used in combination with Indapamide.
Dicloxacillin Dicloxacillin The metabolism of Linagliptin can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Linagliptin can be increased when combined with Nafcillin.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Pentamidine.
Labetalol Labetalol The therapeutic efficacy of Linagliptin can be increased when used in combination with Labetalol.
Leuprolide Injection Leuprolide Injection The therapeutic efficacy of Linagliptin can be decreased when used in combination with Leuprolide.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Linagliptin.
Enalapril Enalapril The risk or severity of angioedema can be increased when Linagliptin is combined with Enalapril.
Amiodarone Amiodarone The metabolism of Amiodarone can be decreased when combined with Linagliptin.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Linagliptin.
Ciprofloxacin Ciprofloxacin The therapeutic efficacy of Linagliptin can be increased when used in combination with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may increase the hypoglycemic activities of Linagliptin.
Diclofenac Diclofenac The risk or severity of angioedema can be increased when Diclofenac is combined with Linagliptin.
Fluoxetine Fluoxetine The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Linagliptin.
Nimodipine Nimodipine The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Linagliptin.
Clozapine Clozapine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Clozapine.
Ofloxacin Ofloxacin The therapeutic efficacy of Linagliptin can be increased when used in combination with Ofloxacin.
Clarithromycin Clarithromycin The metabolism of Linagliptin can be decreased when combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hypoglycemia can be increased when Benazepril is combined with Linagliptin.
Felodipine Felodipine The metabolism of Linagliptin can be decreased when combined with Felodipine.
Fosinopril Fosinopril The risk or severity of angioedema can be increased when Fosinopril is combined with Linagliptin.
Pravastatin Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Linagliptin.
Quinapril Quinapril The risk or severity of angioedema can be increased when Quinapril is combined with Linagliptin.
Ramipril Ramipril The risk or severity of angioedema can be increased when Ramipril is combined with Linagliptin.
Simvastatin Simvastatin The serum concentration of Linagliptin can be increased when it is combined with Simvastatin.
Amlodipine Amlodipine The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Linagliptin.
Teniposide Injection Teniposide Injection The metabolism of Linagliptin can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Linagliptin can be decreased when combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of angioedema can be increased when Lisinopril is combined with Linagliptin.
Rifabutin Rifabutin The metabolism of Linagliptin can be increased when combined with Rifabutin.
Sotalol Sotalol The risk or severity of hypoglycemia can be increased when Sotalol is combined with Linagliptin.
Bisoprolol Bisoprolol The therapeutic efficacy of Linagliptin can be increased when used in combination with Bisoprolol.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Linagliptin.
Isradipine Isradipine The risk or severity of hypoglycemia can be increased when Isradipine is combined with Linagliptin.
Omeprazole Omeprazole The metabolism of Linagliptin can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Linagliptin.
Fluvastatin Fluvastatin The metabolism of Linagliptin can be decreased when combined with Fluvastatin.
Venlafaxine Venlafaxine The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Linagliptin.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Linagliptin.
Fluvoxamine Fluvoxamine The metabolism of Linagliptin can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Linagliptin can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine The serum concentration of Linagliptin can be increased when it is combined with Lamotrigine.
Losartan Losartan The metabolism of Linagliptin can be decreased when combined with Losartan.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Linagliptin.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Linagliptin.
Moexipril Moexipril The risk or severity of angioedema can be increased when Moexipril is combined with Linagliptin.
Lansoprazole Lansoprazole The metabolism of Linagliptin can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Linagliptin can be decreased when combined with Ifosfamide.
Nicardipine Nicardipine The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Linagliptin.
Bupropion Bupropion The excretion of Linagliptin can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Linagliptin.
Saquinavir Saquinavir The metabolism of Linagliptin can be decreased when combined with Saquinavir.
Nisoldipine Nisoldipine The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Linagliptin.
Lamivudine Lamivudine The serum concentration of Lamivudine can be increased when it is combined with Linagliptin.
Acarbose Acarbose The risk or severity of hypoglycemia can be increased when Acarbose is combined with Linagliptin.
Glimepiride Glimepiride Linagliptin may increase the hypoglycemic activities of Glimepiride.
Gemcitabine Injection Gemcitabine Injection The serum concentration of Gemcitabine can be increased when it is combined with Linagliptin.
Indinavir Indinavir The therapeutic efficacy of Linagliptin can be decreased when used in combination with Indinavir.
Ritonavir Ritonavir The serum concentration of Linagliptin can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Linagliptin can be decreased when combined with Docetaxel.
Clomipramine Clomipramine The metabolism of Linagliptin can be decreased when combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Linagliptin can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Linagliptin can be decreased when combined with Mirtazapine.
Trandolapril Trandolapril The risk or severity of angioedema can be increased when Trandolapril is combined with Linagliptin.
Topiramate Topiramate The metabolism of Linagliptin can be increased when combined with Topiramate.
Valsartan Valsartan The risk or severity of angioedema can be increased when Valsartan is combined with Linagliptin.
Insulin Lispro Injection Insulin Lispro Injection Linagliptin may increase the hypoglycemic activities of Insulin lispro.
Pramipexole Pramipexole The serum concentration of Pramipexole can be increased when it is combined with Linagliptin.
Nelfinavir Nelfinavir The therapeutic efficacy of Linagliptin can be decreased when used in combination with Nelfinavir.
Fexofenadine Fexofenadine The serum concentration of Linagliptin can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Linagliptin.
Carvedilol Carvedilol The therapeutic efficacy of Linagliptin can be increased when used in combination with Carvedilol.
Selegiline Selegiline Selegiline may increase the hypoglycemic activities of Linagliptin.
Bicalutamide Bicalutamide The metabolism of Linagliptin can be decreased when combined with Bicalutamide.
Sertraline Sertraline The risk or severity of hypoglycemia can be increased when Sertraline is combined with Linagliptin.
Propafenone Propafenone The therapeutic efficacy of Linagliptin can be increased when used in combination with Propafenone.
Raloxifene Raloxifene The metabolism of Linagliptin can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Linagliptin can be decreased when combined with Irbesartan.
Tamsulosin Tamsulosin The therapeutic efficacy of Linagliptin can be increased when used in combination with Tamsulosin.
Quetiapine Quetiapine The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quetiapine.
Paroxetine Paroxetine The metabolism of Linagliptin can be decreased when combined with Paroxetine.
Citalopram Citalopram The risk or severity of hypoglycemia can be increased when Citalopram is combined with Linagliptin.
Efavirenz Efavirenz The metabolism of Linagliptin can be decreased when combined with Efavirenz.
Sildenafil Sildenafil The serum concentration of Linagliptin can be increased when it is combined with Sildenafil.
Pioglitazone Pioglitazone The risk or severity of hypoglycemia can be increased when Pioglitazone is combined with Linagliptin.
Celecoxib Celecoxib The therapeutic efficacy of Linagliptin can be increased when used in combination with Celecoxib.
Rosiglitazone Rosiglitazone The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Linagliptin.
Balsalazide Balsalazide Balsalazide may increase the hypoglycemic activities of Linagliptin.
Nateglinide Nateglinide The risk or severity of hypoglycemia can be increased when Nateglinide is combined with Linagliptin.
Rabeprazole Rabeprazole The metabolism of Linagliptin can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Linagliptin can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists